You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR PENTOXIL


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for PENTOXIL

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01625845 ↗ Anti-INFLammatory to Address Mood and Endothelial Dysfunction (INFLAMED) Completed National Institute of Mental Health (NIMH) Phase 2 2012-06-01 The objective of this clinical trial is to evaluate whether an anti-inflammatory medication, pentoxifylline, reduces depressive symptoms and improves artery function. Participants in this trial will be older primary care patients (60 years and up) who are depressed but do not have a history of cardiovascular disease. Half of these patients will receive pentoxifylline, and half will receive placebo. In addition, participants in both arms will receive an evidence-based psychological treatment called Beating the Blues®, which is a computerized, cognitive behavioral treatment program for depression. The investigators will use questionnaires to assess change in depressive symptoms and an ultrasound test to measure change in artery function from pre- to post-treatment. It is hypothesized that patients who receive pentoxifylline will show greater improvements in both depression and artery function than patients who receive placebo.
NCT01625845 ↗ Anti-INFLammatory to Address Mood and Endothelial Dysfunction (INFLAMED) Completed Indiana University Phase 2 2012-06-01 The objective of this clinical trial is to evaluate whether an anti-inflammatory medication, pentoxifylline, reduces depressive symptoms and improves artery function. Participants in this trial will be older primary care patients (60 years and up) who are depressed but do not have a history of cardiovascular disease. Half of these patients will receive pentoxifylline, and half will receive placebo. In addition, participants in both arms will receive an evidence-based psychological treatment called Beating the Blues®, which is a computerized, cognitive behavioral treatment program for depression. The investigators will use questionnaires to assess change in depressive symptoms and an ultrasound test to measure change in artery function from pre- to post-treatment. It is hypothesized that patients who receive pentoxifylline will show greater improvements in both depression and artery function than patients who receive placebo.
NCT02487225 ↗ Pentoxifylline Treatment in Acute Pancreatitis (AP) Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Phase 3 2015-05-01 The purpose of this study was to determine the effects (good and bad) of giving a drug called pentoxifylline to patients with acute pancreatitis.
NCT02487225 ↗ Pentoxifylline Treatment in Acute Pancreatitis (AP) Completed Mayo Clinic Phase 3 2015-05-01 The purpose of this study was to determine the effects (good and bad) of giving a drug called pentoxifylline to patients with acute pancreatitis.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for PENTOXIL

Condition Name

Condition Name for PENTOXIL
Intervention Trials
Idiopathic (Unknown) Acute Pancreatitis 1
Acute Pancreatitis (AP) 1
Major Depressive Disorder 1
Alcoholic Pancreatitis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for PENTOXIL
Intervention Trials
Heart Diseases 1
Pancreatitis, Chronic 1
Depressive Disorder, Major 1
Pancreatitis, Alcoholic 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for PENTOXIL

Trials by Country

Trials by Country for PENTOXIL
Location Trials
United States 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for PENTOXIL
Location Trials
Minnesota 1
Indiana 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for PENTOXIL

Clinical Trial Phase

Clinical Trial Phase for PENTOXIL
Clinical Trial Phase Trials
Phase 3 1
Phase 2 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for PENTOXIL
Clinical Trial Phase Trials
Completed 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for PENTOXIL

Sponsor Name

Sponsor Name for PENTOXIL
Sponsor Trials
Indiana University 1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 1
Mayo Clinic 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for PENTOXIL
Sponsor Trials
Other 2
NIH 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.